Find News

Filter articles

Showing 3071 to 3080 of 3671 results

Philippine police raid 'fake' drug call centre


Police in the Philippines have raided a call centre in Manila whose operators had allegedly been selling counterfeit drugs, including copies of Pfizer’s Viagra (sildenafil), over the phone.

Shire v Watson Lialda dispute heads back to district court


The US Court of Appeals for the Federal Circuit has sent a patent dispute between drugs companies Shire and Watson Pharmaceuticals back to a district court, ruling again that the lower court erroneously construed claims related to Lialda.

Pfizer apologises for confusion following Lyrica NHS ruling


Pfizer has apologised to UK-based healthcare providers for any confusion or increased workload following the English High Court’s decision on a patent infringement case centring on its epilepsy drug Lyrica.

Kyle Bass challenges second Vimovo patent


Hedge fund manager Kyle Bass has filed another petition for an inter partes review of a patent covering Horizon Pharma’s arthritis drug Vimovo.

Novartis told to pay 75% of defendants’ costs in Exelon case


The English High Court has ordered Novartis to pay 75% of the defendants’ legal costs in a patent infringement case against Focus Pharmaceuticals, Actavis and Teva.

Federal Circuit hears arguments in Zarxio ‘patent dance’ row


The US Court of Appeals for the Federal Circuit has heard oral arguments in Amgen v Sandoz, a case that should determine whether it is mandatory for biosimilar applicants to engage in the so-called patent dance.

BIO welcomes IPR reforms as PATENT Act works through Congress

US05-06-2015Legal developments

The Biotechnology Industry Organization has supported potential amendments to the Protect American Talent and Entrepreneurship Act, which was approved by the Senate Judiciary Committee yesterday.

Taylor English hires litigator in Atlanta


US law firm Taylor English has added Kelly Mullally to its intellectual property practice in Atlanta.

Prometheus Laboratories asks Federal Circuit to revive Lotronex patent


California-based pharmaceutical company Prometheus Laboratories has asked the US Court of Appeals for the Federal Circuit to reinstate a patent covering its irritable bowel syndrome drug Lotronex.

Former Biogen vice president joins Choate


Robert Licht, former senior vice president of pharmaceutical company Biogen, has joined law firm Choate Hall & Stewart as a partner in the firm’s life sciences group.

Showing 3071 to 3080 of 3671 results